ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Cash flow Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:28 23/01/2026 pm IST			5-day change	1st Jan Change
0.7800 ^HKD	+5.41%		+5.41%	+39.29%

23/01	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025	CI
23/01	Zhongzhi pharmaceutical expects over 70% decrease in 2025 net profit	RE

61dcef.JfLOSwmhvX5DXJ_BtOwJ_8myEV4NEZxn3o4SGopyeCU.abD7OWDSyA8xCazwzbN7yf7LdDhUJ8wjpOJ5ccULTWRyrfkdWMfiGHIm8A

Published financial data: ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	160.39Cr	174.65Cr	182.59Cr	204.98Cr	221.48Cr
Total Revenues	160.39Cr	174.65Cr	182.59Cr	204.98Cr	221.48Cr
Cost of Goods Sold, Total	61Cr	69Cr	76Cr	84Cr	93Cr
Gross Profit	99Cr	106.13Cr	106.73Cr	121.46Cr	128.13Cr
Selling General & Admin Expenses, Total	79Cr	93Cr	91Cr	99Cr	109.45Cr
Other Operating Expenses	5.23Cr	4.96Cr	4.93Cr	5.59Cr	6.17Cr
Other Operating Expenses, Total	84Cr	98Cr	96Cr	105.07Cr	115.62Cr
Operating Income	15Cr	7.96Cr	10Cr	16Cr	13Cr
Interest Expense, Total	-52.18L	-70.8L	-65.55L	-78.68L	-69.94L
Interest And Investment Income	1.01Cr	42.17L	39.97L	70.17L	51.95L
Net Interest Expenses	48.6L	-28.63L	-25.58L	-9L	-17.99L
Other Non Operating Income (Expenses)	1.36Cr	2.46Cr	2.66Cr	4.02Cr	3.28Cr
EBT, Excl. Unusual Items	17Cr	10Cr	13Cr	20Cr	16Cr
Gain (Loss) On Sale Of Investments	78.12L	-3.96Cr	24.31L	38.87L	-97.49L
Gain (Loss) On Sale Of Assets	-2L	1L	7L	4L	5L
Other Unusual Items	-71L	-	-	-	-
EBT, Incl. Unusual Items	17Cr	6.18Cr	13Cr	21Cr	15Cr
Income Tax Expense	2.86Cr	94.47L	2.37Cr	4.34Cr	5.08Cr
Earnings From Continuing Operations	14Cr	5.24Cr	11Cr	16Cr	9.61Cr
Net Income to Company	14Cr	5.24Cr	11Cr	16Cr	9.61Cr
Minority Interest	-87T	-2L	-5L	-13.59L	-9L
Net Income - (IS)	14Cr	5.21Cr	11Cr	16Cr	9.52Cr
Net Income to Common Incl Extra Items	14Cr	5.21Cr	11Cr	16Cr	9.52Cr
Net Income to Common Excl. Extra Items	14Cr	5.21Cr	11Cr	16Cr	9.52Cr
Per Share Items
Net EPS - Basic	0.17	0.06	0.13	0.19	0.11
Basic EPS - Continuing Operations	0.17	0.06	0.13	0.19	0.11
Basic Weighted Average Shares Outstanding	83Cr	84Cr	85Cr	85Cr	85Cr
Net EPS - Diluted	0.17	0.06	0.13	0.19	0.11
Diluted EPS - Continuing Operations	0.17	0.06	0.13	0.19	0.11
Diluted Weighted Average Shares Outstanding	83Cr	84Cr	85Cr	85Cr	85Cr
Normalized Basic EPS	0.13	0.08	0.09	0.15	0.11
Normalized Diluted EPS	0.13	0.08	0.09	0.15	0.11
Dividend Per Share	0.03	-	0.05	0.08	0.05
Payout Ratio	35.35	-	-	71.35	24.3
Supplemental Items
EBITDA	21Cr	12Cr	15Cr	21Cr	17Cr
EBITA	15Cr	8.29Cr	10Cr	16Cr	13Cr
EBIT	15Cr	7.96Cr	10Cr	16Cr	13Cr
EBITDAR	21Cr	13Cr	15Cr	22Cr	17Cr
Effective Tax Rate - (Ratio)	17.1	15.28	18.17	20.93	34.55
Current Domestic Taxes	1.88Cr	2.5Cr	2.04Cr	5.14Cr	4.93Cr
Total Current Taxes	1.88Cr	2.5Cr	2.04Cr	5.14Cr	4.93Cr
Deferred Domestic Taxes	97.53L	-	-	-	-
Total Deferred Taxes	97.53L	-1.56Cr	33.18L	-79.21L	14.24L
Normalized Net Income	10Cr	6.31Cr	7.92Cr	13Cr	9.66Cr
Interest on Long-Term Debt	38.31L	44.07L	46.36L	52.54L	43.6L
Supplemental Operating Expense Items
Marketing Expenses	19Cr	23Cr	18Cr	21Cr	27Cr
Selling and Marketing Expenses	70Cr	83Cr	81Cr	89Cr	99Cr
General and Administrative Expenses	9.18Cr	10Cr	10Cr	11Cr	11Cr
Research And Development Expense From Footnotes	5.02Cr	4.38Cr	4.64Cr	5Cr	5.7Cr
Net Rental Expense, Total	37.85L	35.18L	7L	10L	2L
Imputed Operating Lease Interest Expense	10.02L	10.96L	2L	3L	72.97T
Imputed Operating Lease Depreciation	27.83L	24.22L	5L	6L	2L
Stock-Based Comp., Other (Total)	11.17L	-	-	-	-
Total Stock-Based Compensation	11.17L	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	29Cr	23Cr	38Cr	16Cr	17Cr
Short Term Investments	1.64Cr	1.57Cr	-	2.57Cr	3.26Cr
Trading Asset Securities, Total	6L	87.95L	1.47Cr	22.77L	-
Total Cash And Short Term Investments	31Cr	26Cr	40Cr	19Cr	20Cr
Accounts Receivable, Total	28Cr	29Cr	31Cr	33Cr	44Cr
Other Receivables	21.7L	1.39Cr	-	84.71L	85.29L
Total Receivables	29Cr	31Cr	31Cr	34Cr	45Cr
Inventory	25Cr	27Cr	32Cr	33Cr	35Cr
Restricted Cash	-	-	-	-	21.13L
Other Current Assets, Total	4.05Cr	2.41Cr	6.08Cr	1.53Cr	1.89Cr
Total Current Assets	88Cr	86Cr	109.09Cr	87Cr	101.41Cr
Gross Property Plant And Equipment	65Cr	79Cr	86Cr	99Cr	109.93Cr
Accumulated Depreciation	-21Cr	-25Cr	-29Cr	-33Cr	-37Cr
Net Property Plant And Equipment	43Cr	55Cr	57Cr	66Cr	73Cr
Long-term Investments	2.48Cr	1.7Cr	1.79Cr	4.93Cr	4.4Cr
Goodwill	16.28L	16.28L	16.28L	16.28L	16.28L
Other Intangibles, Total	1.96Cr	1.83Cr	1.54Cr	1.42Cr	1.18Cr
Deferred Tax Assets Long-Term	1.62Cr	3.2Cr	3.02Cr	3.01Cr	2.84Cr
Other Long-Term Assets, Total	4.24Cr	5.05Cr	15Cr	16Cr	16Cr
Total Assets	142.05Cr	152.41Cr	187.53Cr	179.26Cr	198.71Cr
Liabilities
Accounts Payable, Total	11Cr	12Cr	19Cr	19Cr	30Cr
Accrued Expenses, Total	5.47Cr	5.93Cr	8.99Cr	4.67Cr	4.49Cr
Short-term Borrowings	7.89Cr	5.72Cr	3.6Cr	-	-
Current Portion of Long-Term Debt	-	-	-	2.73Cr	4.63Cr
Current Portion of Leases	3.58Cr	3.79Cr	4.02Cr	4.83Cr	3.54Cr
Current Income Taxes Payable	2.66Cr	2.77Cr	3.08Cr	3.96Cr	4.49Cr
Unearned Revenue Current, Total	3.55Cr	2.98Cr	13Cr	3.31Cr	1.38Cr
Other Current Liabilities	14Cr	17Cr	21Cr	22Cr	25Cr
Total Current Liabilities	49Cr	50Cr	73Cr	61Cr	73Cr
Long-Term Debt	-	-	-	2.27Cr	3.83Cr
Long-Term Leases	7.32Cr	8.06Cr	9.46Cr	7.66Cr	6.86Cr
Unearned Revenue Non Current	1.42Cr	1.54Cr	1.58Cr	1.19Cr	79.1L
Deferred Tax Liability Non Current	2.59Cr	2.61Cr	2.76Cr	1.96Cr	1.93Cr
Total Liabilities	60Cr	62Cr	87Cr	74Cr	87Cr
Common Stock, Total	66.5L	68.47L	68.47L	68.47L	68.47L
Additional Paid In Capital	17Cr	20Cr	20Cr	8.67Cr	6.36Cr
Retained Earnings	61Cr	66Cr	76Cr	93Cr	102.25Cr
Comprehensive Income and Other	3.45Cr	3.09Cr	2.88Cr	2.77Cr	2.36Cr
Total Common Equity	82Cr	90Cr	100.3Cr	104.85Cr	111.65Cr
Minority Interest	15.87L	24.25L	29.73L	48.17L	50.2L
Total Equity	82Cr	90Cr	100.59Cr	105.33Cr	112.15Cr
Total Liabilities And Equity	142.05Cr	152.41Cr	187.53Cr	179.26Cr	198.71Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	84Cr	86Cr	86Cr	86Cr	86Cr
ECS Total Common Shares Outstanding	84Cr	86Cr	86Cr	86Cr	86Cr
Book Value / Share	0.98	1.04	1.16	1.21	1.29
Tangible Book Value	80Cr	88Cr	99Cr	103.27Cr	110.3Cr
Tangible Book Value Per Share	0.95	1.02	1.14	1.2	1.28
Total Debt	19Cr	18Cr	17Cr	17Cr	19Cr
Net Debt	-12Cr	-8.21Cr	-22Cr	-1.74Cr	-1.11Cr
Debt Equivalent Oper. Leases	3.03Cr	2.81Cr	58.96L	76.16L	18.96L
Minority Interest, Total (Incl. Fin. Div)	15.87L	24.25L	29.73L	48.17L	50.2L
Equity Method Investments, Total	4L	4L	4L	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	4.68Cr	4.54Cr	5.66Cr	7.11Cr	8.76Cr
Inventories - Work In Process, Total	1.16Cr	1.52Cr	1.27Cr	1.96Cr	2.88Cr
Inventories - Finished Goods, Total	19Cr	21Cr	25Cr	24Cr	23Cr
Buildings, Total	20Cr	19Cr	27Cr	28Cr	27Cr
Machinery, Total	14Cr	18Cr	22Cr	25Cr	27Cr
Full Time Employees	4.19T	3.15T	2.88T	2.64T	2.58T
Accumulated Allowance for Doubtful Accounts (Supple)	31.07L	35.49L	33.87L	38.61L	79.61L

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	14Cr	5.21Cr	11Cr	16Cr	9.52Cr
Depreciation & Amortization - CF	9.69Cr	8.18Cr	9.28Cr	9.86Cr	11Cr
Amortization of Goodwill and Intangible Assets - (CF)	6L	32.82L	8L	8L	2L
Depreciation & Amortization, Total	9.75Cr	8.51Cr	9.36Cr	9.95Cr	11Cr
Amortization of Deferred Charges, Total - (CF)	22.02L	-	28L	26.01L	32.87L
(Gain) Loss From Sale Of Asset	2L	-1L	-7L	-4L	11.99L
(Gain) Loss on Sale of Investments - (CF)	-75.09L	4.04Cr	-24.31L	-36.12L	39.02L
Stock-Based Compensation (CF)	11.17L	-	-	-	-
Provision and Write-off of Bad Debts	4L	4L	-2L	5L	41L
Other Operating Activities, Total	-90.43L	-2.78Cr	-30.39L	-1.54Cr	-11.57L
Change In Accounts Receivable	-5.3Cr	1Cr	-1.36Cr	-1.82Cr	-12Cr
Change In Inventories	-4.82Cr	-2.1Cr	-5.98Cr	-1.07Cr	-2.24Cr
Change In Accounts Payable	61.39L	1.04Cr	6.9Cr	11.91L	10Cr
Change in Unearned Revenues	95.11L	1.06Cr	1.05Cr	86.65L	48.81L
Change in Other Net Operating Assets	-4.47Cr	1.83Cr	8.2Cr	-13Cr	-9L
Cash from Operations	9.32Cr	18Cr	28Cr	10Cr	18Cr
Capital Expenditure	-11Cr	-19Cr	-8.84Cr	-17Cr	-14Cr
Sale of Property, Plant, and Equipment	92.2L	25.27L	2.18Cr	1.71Cr	38.22L
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-38.4L	-20.14L	-7L	-22.51L	-11.02L
Investment in Marketable and Equity Securities, Total	-14Cr	2.27Cr	7.09Cr	-5.54Cr	32.42L
Other Investing Activities, Total	15.76L	2.67Cr	97.57L	70.17L	1.47Cr
Cash from Investing	-25Cr	-14Cr	1.34Cr	-20Cr	-12Cr
Short Term Debt Issued, Total	7.89Cr	12Cr	1.05Cr	-	-
Long-Term Debt Issued, Total	-	-	-	4.97Cr	5.24Cr
Total Debt Issued	7.89Cr	12Cr	1.05Cr	4.97Cr	5.24Cr
Short Term Debt Repaid, Total	-3.14Cr	-15Cr	-3.17Cr	-	-
Long-Term Debt Repaid, Total	-3.83Cr	-4.54Cr	-4.7Cr	-8.86Cr	-8.36Cr
Total Debt Repaid	-6.96Cr	-19Cr	-7.87Cr	-8.86Cr	-8.36Cr
Issuance of Common Stock	-	3Cr	-	-	-
Repurchase of Common Stock	-1.23Cr	-43.83L	-	-	-35.73L
Common Dividends Paid	-4.9Cr	-	-	-12Cr	-2.31Cr
Common & Preferred Stock Dividends Paid	-4.9Cr	-	-	-12Cr	-2.31Cr
Special Dividend Paid	-2.14Cr	-	-	-	-
Other Financing Activities, Total	15L	6L	20T	5L	-7L
Cash from Financing	-7.19Cr	-4.08Cr	-6.81Cr	-15Cr	-5.87Cr
Foreign Exchange Rate Adjustments	-1L	8L	-21.81L	-8L	54T
Net Change in Cash	-23Cr	23.49L	23Cr	-26Cr	27.35L
Supplemental Items
Cash Interest Paid	13.87L	26.73L	19.19L	26.14L	26.34L
Cash Income Tax Paid (Refund)	2.2Cr	2.39Cr	1.74Cr	4.25Cr	4.4Cr
Levered Free Cash Flow	-3.79Cr	-4.93Cr	22Cr	-10Cr	2.76Cr
Unlevered Free Cash Flow	-3.46Cr	-4.49Cr	23Cr	-9.91Cr	3.19Cr
Change In Net Working Capital	11Cr	-81.84L	-15Cr	13Cr	1.58Cr
Net Debt Issued / Repaid	92.99L	-6.71Cr	-6.82Cr	-3.9Cr	-3.13Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.86	3.38	3.81	5.59	4.14
Return on Total Capital	9.75	4.77	5.74	8.52	6.16
Return On Equity %	17.49	6.08	11.21	15.94	8.84
Return on Common Equity	17.5	6.07	11.19	15.87	8.8
Margin Analysis
Gross Profit Margin %	61.79	60.77	58.45	59.25	57.85
SG&A Margin	49.29	53.37	50.09	48.53	49.42
EBITDA Margin %	13.01	7	8.43	10.48	7.78
EBITA Margin %	9.28	4.74	5.71	8.04	5.66
EBIT Margin %	9.24	4.56	5.67	8	5.65
Income From Continuing Operations Margin %	8.64	3	5.86	8.01	4.34
Net Income Margin %	8.64	2.98	5.83	7.94	4.3
Net Avail. For Common Margin %	8.64	2.98	5.83	7.94	4.3
Normalized Net Income Margin	6.49	3.61	4.34	6.13	4.36
Levered Free Cash Flow Margin	-2.36	-2.82	12.13	-5.08	1.24
Unlevered Free Cash Flow Margin	-2.16	-2.57	12.35	-4.84	1.44
Asset Turnover
Asset Turnover	1.19	1.19	1.07	1.12	1.17
Fixed Assets Turnover	3.91	3.57	3.26	3.31	3.18
Receivables Turnover (Average Receivables)	6.1	6.06	6.03	6.41	5.77
Inventory Turnover (Average Inventory)	2.75	2.66	2.57	2.56	2.76
Short Term Liquidity
Current Ratio	1.82	1.71	1.49	1.44	1.39
Quick Ratio	1.23	1.13	0.97	0.87	0.89
Operating Cash Flow to Current Liabilities	0.19	0.36	0.39	0.17	0.25
Days Sales Outstanding (Average Receivables)	60	60.26	60.48	56.94	63.42
Days Outstanding Inventory (Average Inventory)	133.24	137.22	142.17	142.67	132.4
Average Days Payable Outstanding	59.46	59.77	69.69	82.49	93.92
Cash Conversion Cycle (Average Days)	133.77	137.71	132.97	117.11	101.91
Long Term Solvency
Total Debt/Equity	22.87	19.5	16.98	16.6	16.82
Total Debt / Total Capital	18.61	16.32	14.52	14.24	14.4
LT Debt/Equity	8.91	8.95	9.41	9.42	9.53
Long-Term Debt / Total Capital	7.25	7.49	8.04	8.08	8.16
Total Liabilities / Total Assets	42.15	40.87	46.36	41.24	43.56
EBIT / Interest Expense	28.4	11.24	15.79	20.83	17.89
EBITDA / Interest Expense	47.1	23.25	30.07	33.48	33.35
(EBITDA - Capex) / Interest Expense	25.25	-3	16.58	11.98	13.23
Total Debt / EBITDA	0.76	1.07	0.87	0.66	0.81
Net Debt / EBITDA	-0.5	-0.5	-1.14	-0.07	-0.05
Total Debt / (EBITDA - Capex)	1.43	-8.28	1.57	1.86	2.04
Net Debt / (EBITDA - Capex)	-0.93	3.87	-2.07	-0.19	-0.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.5	8.89	4.55	12.26	8.05
Gross Profit, 1 Yr. Growth %	18.8	7.09	0.57	13.8	5.49
EBITDA, 1 Yr. Growth %	25.29	-39.96	28.53	39.61	-19.96
EBITA, 1 Yr. Growth %	8.71	-42.44	29.99	57.9	-24.15
EBIT, 1 Yr. Growth %	8.37	-43.61	30.07	58.37	-23.88
Earnings From Cont. Operations, 1 Yr. Growth %	20.86	-62.22	104.17	53.52	-41.42
Net Income, 1 Yr. Growth %	20.78	-62.37	104.09	53	-41.51
Normalized Net Income, 1 Yr. Growth %	13.19	-36.71	25.51	58.74	-23.3
Diluted EPS Before Extra, 1 Yr. Growth %	21.45	-64.1	109.34	51.27	-42.11
Accounts Receivable, 1 Yr. Growth %	16.61	3.7	6.13	5.27	34.02
Inventory, 1 Yr. Growth %	24.16	8.47	20.46	2.2	4.65
Net Property, Plant and Equip., 1 Yr. Growth %	11.08	26.69	4.8	15.78	9.99
Total Assets, 1 Yr. Growth %	10.93	7.29	23.04	-4.41	10.85
Tangible Book Value, 1 Yr. Growth %	7.51	9.99	12.19	4.74	6.82
Common Equity, 1 Yr. Growth %	7.44	9.58	11.6	4.54	6.49
Cash From Operations, 1 Yr. Growth %	-44.48	91.44	59.53	-64.33	78.79
Capital Expenditures, 1 Yr. Growth %	99.39	63.04	-52.43	91.36	-16.8
Levered Free Cash Flow, 1 Yr. Growth %	-159.98	16.49	-549.14	-142.44	-126.57
Unlevered Free Cash Flow, 1 Yr. Growth %	-152.73	14.89	-602.53	-139.77	-132.31
Dividend Per Share, 1 Yr. Growth %	-42.39	-	-	53.92	-42.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.5	14.07	6.7	8.34	10.13
Gross Profit, 2 Yr. CAGR %	18.7	12.79	3.78	6.98	9.57
EBITDA, 2 Yr. CAGR %	42.7	-14.29	-13.09	33.96	5.83
EBITA, 2 Yr. CAGR %	37.97	-22.21	-14.87	43.27	9.6
EBIT, 2 Yr. CAGR %	37.67	-23.72	-14.36	43.53	9.95
Earnings From Cont. Operations, 2 Yr. CAGR %	27.65	-32.43	-12.18	77.04	-5.17
Net Income, 2 Yr. CAGR %	27.61	-32.58	-12.37	76.71	-5.4
Normalized Net Income, 2 Yr. CAGR %	30.22	-17.19	-10.88	41.15	10.47
Diluted EPS Before Extra, 2 Yr. CAGR %	29.29	-33.97	-13.31	77.95	-6.42
Accounts Receivable, 2 Yr. CAGR %	32.18	9.97	4.91	5.7	18.78
Inventory, 2 Yr. CAGR %	17.5	16.05	14.31	10.96	3.42
Net Property, Plant and Equip., 2 Yr. CAGR %	29.79	18.63	15.23	10.16	12.85
Total Assets, 2 Yr. CAGR %	18.51	9.1	14.9	8.45	2.94
Tangible Book Value, 2 Yr. CAGR %	7.14	8.74	11.09	8.4	5.77
Common Equity, 2 Yr. CAGR %	7.74	8.5	10.58	8.01	5.51
Cash From Operations, 2 Yr. CAGR %	8.04	3.1	74.76	-24.57	-20.14
Capital Expenditures, 2 Yr. CAGR %	23.12	80.3	-11.93	-4.59	26.18
Levered Free Cash Flow, 2 Yr. CAGR %	60.77	-11.65	128.74	45.26	-66.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	54.48	-17.33	140.28	48.61	-64.2
Dividend Per Share, 2 Yr. CAGR %	-12.66	-	30.52	-	-5.91
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.3	15.21	10.8	8.52	8.24
Gross Profit, 3 Yr. CAGR %	20.86	14.7	8.56	7.01	6.48
EBITDA, 3 Yr. CAGR %	29.16	6.09	-2.59	1.79	12.91
EBITA, 3 Yr. CAGR %	25.98	1.95	-8.66	4.6	16.01
EBIT, 3 Yr. CAGR %	25.8	0.58	-8.87	5.12	16.29
Earnings From Cont. Operations, 3 Yr. CAGR %	25.54	-14.93	-2.31	5.79	22.45
Net Income, 3 Yr. CAGR %	25.52	-15.06	-2.48	5.52	22.24
Normalized Net Income, 3 Yr. CAGR %	22.6	0.9	-4.88	8.03	15.27
Diluted EPS Before Extra, 3 Yr. CAGR %	24.36	-15.66	-3	4.36	22.39
Accounts Receivable, 3 Yr. CAGR %	33.75	21.91	8.67	5.03	14.4
Inventory, 3 Yr. CAGR %	21.46	14.41	17.5	10.12	8.81
Net Property, Plant and Equip., 3 Yr. CAGR %	28.58	28.75	13.83	15.41	10.1
Total Assets, 3 Yr. CAGR %	15.92	14.64	13.56	8.06	9.25
Tangible Book Value, 3 Yr. CAGR %	6.78	8.08	9.88	8.93	7.87
Common Equity, 3 Yr. CAGR %	7.07	8.35	9.53	8.53	7.5
Cash From Operations, 3 Yr. CAGR %	22.1	30.74	19.25	2.89	0.58
Capital Expenditures, 3 Yr. CAGR %	34.66	35.21	15.64	14.07	-8.85
Levered Free Cash Flow, 3 Yr. CAGR %	58.99	49.83	51.91	34.96	-17.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	54.29	45.7	50.87	36.39	-10.73
Dividend Per Share, 3 Yr. CAGR %	-2.89	-	-0.63	37.9	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.44	19.05	14.09	12.41	10.54
Gross Profit, 5 Yr. CAGR %	21.45	21.59	13.71	11.54	8.96
EBITDA, 5 Yr. CAGR %	14.33	12.31	9.71	15.96	0.69
EBITA, 5 Yr. CAGR %	10.4	12.1	6.98	16.07	-1.76
EBIT, 5 Yr. CAGR %	10.31	11.2	6.81	15.95	-1.76
Earnings From Cont. Operations, 5 Yr. CAGR %	11.47	-0.57	8.82	14.05	-3.47
Net Income, 5 Yr. CAGR %	11.46	-0.66	8.71	13.86	-3.65
Normalized Net Income, 5 Yr. CAGR %	10.44	7.83	6.98	15.4	0.99
Diluted EPS Before Extra, 5 Yr. CAGR %	7.56	-2.27	7.64	13.7	-4.38
Accounts Receivable, 5 Yr. CAGR %	38.06	35.67	21.37	15.15	12.61
Inventory, 5 Yr. CAGR %	19.86	17.23	18.55	13.02	11.65
Net Property, Plant and Equip., 5 Yr. CAGR %	37.12	24.9	23.07	20.96	13.44
Total Assets, 5 Yr. CAGR %	14.45	15.08	15.51	12.13	9.19
Tangible Book Value, 5 Yr. CAGR %	7.4	9.24	8.48	8.21	8.22
Common Equity, 5 Yr. CAGR %	7.83	9.6	8.46	8.21	7.9
Cash From Operations, 5 Yr. CAGR %	10.7	29.47	40.93	4.92	1.58
Capital Expenditures, 5 Yr. CAGR %	29.62	10.85	13.62	17.61	19.75
Levered Free Cash Flow, 5 Yr. CAGR %	32.02	-6.89	88	47.98	-15.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	28.45	-8.62	88.7	46.86	-13.43
Dividend Per Share, 5 Yr. CAGR %	1.22	-	9.3	14.87	-2.77